应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01681 康臣药业
已收盘 07-19 16:08:12
5.790
-0.100
-1.70%
最高
5.910
最低
5.720
成交量
329.40万
今开
5.910
昨收
5.890
日振幅
3.23%
总市值
48.89亿
流通市值
48.89亿
总股本
8.44亿
成交额
1,899万
换手率
0.39%
流通股本
8.44亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康臣药业:SK-08片剂临床试验申请获《药物临床试验批准通知书》
新浪港股 · 07-18 07:53
康臣药业:SK-08片剂临床试验申请获《药物临床试验批准通知书》
康臣药业(01681):SK-08片剂临床试验申请获《药物临床试验批准通知书》
智通财经 · 07-18 06:31
康臣药业(01681):SK-08片剂临床试验申请获《药物临床试验批准通知书》
康臣药业(01681)上涨5.32%,报5.94元/股
金融界 · 07-11
康臣药业(01681)上涨5.32%,报5.94元/股
康臣药业盘中异动 急速拉升5.34%报5.941港元
自选股智能写手 · 07-11
康臣药业盘中异动 急速拉升5.34%报5.941港元
康臣药业07月10日遭主力抛售218万元 环比增加384.44%
自选股智能写手 · 07-10
康臣药业07月10日遭主力抛售218万元 环比增加384.44%
康臣药业(1681.HK):管理层大笔增持,提振市场信心
格隆汇 · 07-10
康臣药业(1681.HK):管理层大笔增持,提振市场信心
董事局主席安猛连续三个交易日增持康臣药业(01681)共计147.3万股 涉资约864.65万港元
智通财经网 · 07-08
董事局主席安猛连续三个交易日增持康臣药业(01681)共计147.3万股 涉资约864.65万港元
康臣药业07月08日主力资金流出188万元 连续7日减仓
自选股智能写手 · 07-08
康臣药业07月08日主力资金流出188万元 连续7日减仓
康臣药业07月04日遭主力抛售578万元 环比增加932.14%
自选股智能写手 · 07-04
康臣药业07月04日遭主力抛售578万元 环比增加932.14%
康臣药业07月02日主力资金流出5万元 连续3日减仓
自选股智能写手 · 07-02
康臣药业07月02日主力资金流出5万元 连续3日减仓
康臣药业(1681.HK)亮相“2024格隆汇中期策略会”,高分红稳增长成焦点
格隆汇 · 06-30
康臣药业(1681.HK)亮相“2024格隆汇中期策略会”,高分红稳增长成焦点
中国中药企业百强榜发布,康臣药业蝉联第22位
南方plus客户端 · 06-28
中国中药企业百强榜发布,康臣药业蝉联第22位
安信国际:首予康臣药业(01681)“增持”评级 罗沙司他胶囊等三款产品预计于2024年获批上市
智通财经 · 06-21
安信国际:首予康臣药业(01681)“增持”评级 罗沙司他胶囊等三款产品预计于2024年获批上市
康臣药业(01681)委任李义凯为独立非执行董事
智通财经 · 06-21
康臣药业(01681)委任李义凯为独立非执行董事
康臣药业(内蒙古)有限责任公司药品申请临床试验默示许可获受理
金融界 · 06-13
康臣药业(内蒙古)有限责任公司药品申请临床试验默示许可获受理
高股息与稳增长逻辑获市场青睐,康臣药业价值回归在路上
格隆汇资讯 · 06-11
高股息与稳增长逻辑获市场青睐,康臣药业价值回归在路上
康臣药业近期因购股权获行使合共发行约150.83万股股份
新浪港股 · 06-07
康臣药业近期因购股权获行使合共发行约150.83万股股份
康臣药业(01681)近期因购股权获行使合共发行约150.83万股股份
智通财经 · 06-06
康臣药业(01681)近期因购股权获行使合共发行约150.83万股股份
康臣药业将于6月21日派发特别股息每股0.3港元
新浪港股 · 05-24
康臣药业将于6月21日派发特别股息每股0.3港元
康臣药业(01681)将于6月21日派发特别股息每股0.3港元
智通财经网 · 05-24
康臣药业(01681)将于6月21日派发特别股息每股0.3港元
加载更多
公司概况
公司名称:
康臣药业
所属市场:
SEHK
上市日期:
--
主营业务:
康臣药业集团有限公司是一家投资控股公司,主要从事生产和销售药品业务。该公司的药品包括肾病药物、对比剂及其他。该公司的子公司包括智达集团有限公司、世纪国际拓展有限公司和宏致有限公司。该公司通过其子公司还从事研发药品业务。
发行价格:
--
{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"康臣药业","latestPrice":5.79,"timestamp":1721376492013,"preClose":5.89,"halted":0,"volume":3294000,"delay":0,"floatShares":844470255,"shares":844470255,"eps":1.0632643,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.1,"latestTime":"07-19 16:08:12","open":5.91,"high":5.91,"low":5.72,"amount":18986010,"amplitude":0.032258,"askPrice":5.79,"askSize":21000,"bidPrice":5.76,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":1.0504657191941276,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":5.89,"dividendRate":0.075707,"openAndCloseTimeList":[[1721352600000,1721361600000],[1721365200000,1721376000000]],"volumeRatio":1.146824,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681","defaultTab":"news","newsList":[{"id":"2452114390","title":"康臣药业:SK-08片剂临床试验申请获《药物临床试验批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2452114390","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452114390?lang=zh_cn&edition=full","pubTime":"2024-07-18 07:53","pubTimestamp":1721260389,"startTime":"0","endTime":"0","summary":"康臣药业(01681)发布公告,公司收到中国国家药品监督管理局(NMPA)核准签发的有关SK-08片剂(SK-08片)的临床试验申请获得批准的《药物临床试验批准通知书》。\n SK-08片为集团和上海药明康德新药开发有限公司联合研发的一类化学新药。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-18/doc-incepaac9759921.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-18/doc-incepaac9759921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["03347","01681","BK1141","BK1583","BK1576","BK1191","BK1606"],"gpt_icon":0},{"id":"2452152491","title":"康臣药业(01681):SK-08片剂临床试验申请获《药物临床试验批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2452152491","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452152491?lang=zh_cn&edition=full","pubTime":"2024-07-18 06:31","pubTimestamp":1721255489,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业 发布公告,公司收到中国国家药品监督管理局核准签发的有关SK-08片剂的临床试验申请获得批准的《药物临床试验批准通知书》。SK-08片为集团和上海药明康德新药开发有限公司联合研发的一类化学新药。有显著的未满足的临床需求。公司将继续积极推进SK-08片的临床试验,争取早日上市造福广大患者。同时,该产品临床试验批件的获得,将进一步丰富集团慢性肾病领域的在研产品管线组合,有助于集团在肾病治疗领域的发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1583","BK1191","01681","03347","BK1141","BK1606"],"gpt_icon":0},{"id":"2450680383","title":"康臣药业(01681)上涨5.32%,报5.94元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450680383","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450680383?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:43","pubTimestamp":1720665796,"startTime":"0","endTime":"0","summary":"7月11日,康臣药业(01681)盘中上涨5.32%,截至10:43,报5.94元/股,成交173.44万元。康臣药业集团是一家制药企业,以研发、生产和营销肾科、影像、妇儿、骨伤、皮肤、肝胆、消化系列药品为主要业务,拥有138个品种药品,其中33个品种进入国家基本药物目录,67个品种进入国家医保目录。康臣药业的关键经营数据表现在其当下拥有广东广州、内蒙古通辽、广西玉林、新疆霍尔果斯等4个生产基地,员工逾3000人,且其分销网络遍布全国,业绩长期保持稳定高速增长。截至2023年年报,康臣药业营业总收入25.9亿元、净利润7.85亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/11104341505561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2450803309","title":"康臣药业盘中异动 急速拉升5.34%报5.941港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450803309","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450803309?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:43","pubTimestamp":1720665788,"startTime":"0","endTime":"0","summary":"2024年07月11日早盘10时43分,康臣药业股票出现波动,股价大幅拉升5.34%。康臣药业股票所在的药品行业中,整体涨幅为0.35%。消息层面,截至10时43分,康臣药业股票正面舆情新闻比例100%。该信息摘要如下:7月8日报道,根据香港联交所7月8日披露的文件,安猛于7月4日以每股均价5.73港元增持$康臣药业 $5万股普通股股份,价值约28.65万港元。增持后,安猛最新持股数目为2.12亿股股份,好仓比例由25.10%升至25.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711104308af91bd75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711104308af91bd75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2450785082","title":"康臣药业07月10日遭主力抛售218万元 环比增加384.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450785082","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450785082?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:16","pubTimestamp":1720599370,"startTime":"0","endTime":"0","summary":"07月10日, 康臣药业股价跌3.26%,报收5.64元,成交金额2266万元,换手率0.47%,振幅4.29%,量比1.25。康臣药业今日主力资金净流出218万元,上一交易日主力净流出45万元,今日环比增加384.44%。该股近5个交易日下跌0.18%,主力资金累计净流出1328万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出1677万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101616339f2b9335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101616339f2b9335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2450883343","title":"康臣药业(1681.HK):管理层大笔增持,提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2450883343","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450883343?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:36","pubTimestamp":1720571793,"startTime":"0","endTime":"0","summary":"2024年上半年,在价值股获得市场资金偏好的大背景下,康臣药业凭借其多年稳健增长的业绩表现和持续的高比例分红策略,获得众多投资者和分析师的看好,前复权股价累计上涨逾33%,期间股价振幅逾51%,最高价达7.16港元,明显跑赢恒生指数和港股医药板块。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/110.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/841672","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2449784837","title":"董事局主席安猛连续三个交易日增持康臣药业(01681)共计147.3万股 涉资约864.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449784837","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449784837?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:40","pubTimestamp":1720435242,"startTime":"0","endTime":"0","summary":"7月3日-7月5日,董事局主席安猛连续三个交易日增持康臣药业(01681)共计147.3万股,涉资约864.65万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20240708/20240708183940_40568.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240708/20240708183940_40568.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2449725213","title":"康臣药业07月08日主力资金流出188万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2449725213","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449725213?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:16","pubTimestamp":1720426572,"startTime":"0","endTime":"0","summary":"07月08日, 康臣药业股价跌2.54%,报收5.75元,成交金额1548万元,换手率0.32%,振幅3.05%,量比0.99。康臣药业今日主力资金净流出188万元,连续7日净流出,上一交易日主力净流出301万元,今日环比减少37.54%。该股近5个交易日上涨3.42%,主力资金累计净流出1126万元;近20日主力资金累计净流出1415万元,其中净流出天数为7日。该股主力净额占比0.04%,港股市场排名2530/2643。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081617029f1d608a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081617029f1d608a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2448145494","title":"康臣药业07月04日遭主力抛售578万元 环比增加932.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448145494","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448145494?lang=zh_cn&edition=full","pubTime":"2024-07-04 16:16","pubTimestamp":1720081000,"startTime":"0","endTime":"0","summary":"07月04日, 康臣药业股价涨2.64%,报收5.83元,成交金额2148万元,换手率0.44%,振幅2.46%,量比2.43。康臣药业今日主力资金净流出578万元,连续5日净流出,上一交易日主力净流出56万元,今日环比增加932.14%。该股近5个交易日上涨7.96%,主力资金累计净流出1057万元;近20日主力资金累计净流出930万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407041617129f01dddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407041617129f01dddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"gpt_icon":0},{"id":"2448665184","title":"康臣药业07月02日主力资金流出5万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2448665184","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448665184?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:16","pubTimestamp":1719908181,"startTime":"0","endTime":"0","summary":"07月02日, 康臣药业股价涨0.72%,报收5.60元,成交金额678万元,换手率0.14%,振幅2.70%,量比0.72。康臣药业今日主力资金净流出5万元,连续3日净流出,上一交易日主力净流出271万元,今日环比减少98.15%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为2.24%。该股近5个交易日上涨3.51%,主力资金累计净流出424万元;近20日主力资金累计净流出297万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021616359565247f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021616359565247f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2447605180","title":"康臣药业(1681.HK)亮相“2024格隆汇中期策略会”,高分红稳增长成焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2447605180","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2447605180?lang=zh_cn&edition=full","pubTime":"2024-06-30 21:57","pubTimestamp":1719755858,"startTime":"0","endTime":"0","summary":"高分红,稳增长,使得康臣药业成为港股医药板块一道靓丽的风景线。","market":"us","thumbnail":"https://img2.gelonghui.com/e55e7-c31b999a-a275-4be0-8d81-0d447e1bcad3.jpg?guru_height=1080&guru_width=1920","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/e55e7-c31b999a-a275-4be0-8d81-0d447e1bcad3.jpg?guru_height=1080&guru_width=1920"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/820637","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1191","01681","BK1606"],"gpt_icon":0},{"id":"2446965510","title":"中国中药企业百强榜发布,康臣药业蝉联第22位","url":"https://stock-news.laohu8.com/highlight/detail?id=2446965510","media":"南方plus客户端","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446965510?lang=zh_cn&edition=full","pubTime":"2024-06-28 09:48","pubTimestamp":1719539285,"startTime":"0","endTime":"0","summary":"6月25日-28日,“2024 中国医药 健康产业 共生大会(米思会)”在浙江湖州召开,“2023年度中国医药工业百强系列榜单”重磅发布。康臣药业 集团蝉联“2023年度 中国 中药 企业TOP100排行榜”第22位。2024米思会发布的“中国医药工业百强系列榜单”由米内网发起主办,旨在为国内医药工业企业提升 综合 实力和扩大品牌效力树立标杆,展示医药品牌工业卓越风采。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281030349f6e08b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406281030349f6e08b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00570","BK1515","BK1606","01681","BK1191"],"gpt_icon":0},{"id":"2445738408","title":"安信国际:首予康臣药业(01681)“增持”评级 罗沙司他胶囊等三款产品预计于2024年获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2445738408","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445738408?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:19","pubTimestamp":1718957949,"startTime":"0","endTime":"0","summary":"自2019年纳入医保目录,益肾化湿颗粒保持较快的增长势头,2023年收入同比增长26%。在研管线步入收获期,3款产品预计于今年上市。仿制药中,碘克沙醇注射液、碘普罗胺注射液和罗沙司他胶囊预计于2024年获批上市;碳酸镧、恩格列净、钆特酸葡胺注射液、钆塞酸二钠注射液和八氟丙烷脂质微球注射液将提交上市注册申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1138545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681"],"gpt_icon":0},{"id":"2445202360","title":"康臣药业(01681)委任李义凯为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2445202360","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445202360?lang=zh_cn&edition=full","pubTime":"2024-06-21 12:20","pubTimestamp":1718943610,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)公布,李义凯获委任为公司独立非执行董事、提名委员会主席及审核委员会成员,自2024年6月21日起生效。同日起,张丽华已不再担任审核委员会成员,冯仲实已不再担任提名委员会主席及成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1138475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1606","BK1191"],"gpt_icon":0},{"id":"2443526364","title":"康臣药业(内蒙古)有限责任公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2443526364","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443526364?lang=zh_cn&edition=full","pubTime":"2024-06-13 12:58","pubTimestamp":1718254695,"startTime":"0","endTime":"0","summary":"6月13日,据CDE官网消息,康臣药业(内蒙古)有限责任公司联合申请药品“SK-08片”,获得临床试验默示许可,受理号CXHL2400315。公示信息显示,药品“SK-08片”适应症:本品拟用于慢性肾病(CKD)的治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406131302259f377f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406131302259f377f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1576","03347","BK1583","BK1141","BK1191","01681"],"gpt_icon":0},{"id":"2442236452","title":"高股息与稳增长逻辑获市场青睐,康臣药业价值回归在路上","url":"https://stock-news.laohu8.com/highlight/detail?id=2442236452","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442236452?lang=zh_cn&edition=full","pubTime":"2024-06-11 19:10","pubTimestamp":1718104251,"startTime":"0","endTime":"0","summary":"近日,康臣药业发布公告,为庆祝公司股份在香港联合交易所主板上市十周年,并感谢股东们的长期支持,董事局决定宣派每股0.3港元的特别股息。值得一提的是,这已经是康臣药业自上市以来第19次分红派息,累计派息金额将达22亿港元。其中,康臣药业凭借高股息率以及有稳健的盈利能力位列第一。根据WIND数据显示,尽管港股和A股市场整体承受着不小的压力,但康臣药业自今年年初以来,其股价累计涨幅已超过30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061119110595a4a0a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061119110595a4a0a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"gpt_icon":0},{"id":"2441599771","title":"康臣药业近期因购股权获行使合共发行约150.83万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441599771","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441599771?lang=zh_cn&edition=full","pubTime":"2024-06-07 07:26","pubTimestamp":1717716419,"startTime":"0","endTime":"0","summary":"康臣药业(01681)公布,2024年6月3日-6日,因购股权获行使合共发行约150.83万股股份。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-07/doc-inaxwhnh4291880.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-06-07/doc-inaxwhnh4291880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2441748168","title":"康臣药业(01681)近期因购股权获行使合共发行约150.83万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441748168","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441748168?lang=zh_cn&edition=full","pubTime":"2024-06-06 22:11","pubTimestamp":1717683098,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)公布,2024年6月3日-6日,因购股权获行使合共发行约150.83万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2437775679","title":"康臣药业将于6月21日派发特别股息每股0.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437775679","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437775679?lang=zh_cn&edition=full","pubTime":"2024-05-24 12:28","pubTimestamp":1716524903,"startTime":"0","endTime":"0","summary":"康臣药业(01681)发布公告,该公司将于2024年6月21日派发特别股息每股0.3港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-24/doc-inawhzmv6908575.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-24/doc-inawhzmv6908575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["01681","BK1191","BK1606"],"gpt_icon":0},{"id":"2437577328","title":"康臣药业(01681)将于6月21日派发特别股息每股0.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437577328","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437577328?lang=zh_cn&edition=full","pubTime":"2024-05-24 12:21","pubTimestamp":1716524490,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)发布公告,该公司将于2024年6月21日派发特别股息每股0.3港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1125625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","01681","BK1606"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0768},{"period":"3month","weight":0.1638},{"period":"6month","weight":0.2785},{"period":"1year","weight":0.2658},{"period":"ytd","weight":0.3615}],"compareEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":-0.0077},{"period":"3month","weight":0.0958},{"period":"6month","weight":0.1613},{"period":"1year","weight":-0.0619},{"period":"ytd","weight":0.0429}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康臣药业集团有限公司是一家投资控股公司,主要从事生产和销售药品业务。该公司的药品包括肾病药物、对比剂及其他。该公司的子公司包括智达集团有限公司、世纪国际拓展有限公司和宏致有限公司。该公司通过其子公司还从事研发药品业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.04268},{"month":2,"riseRate":0.545455,"avgChangeRate":0.018785},{"month":3,"riseRate":0.454545,"avgChangeRate":0.012995},{"month":4,"riseRate":0.727273,"avgChangeRate":0.072429},{"month":5,"riseRate":0.545455,"avgChangeRate":0.02529},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.005392},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.026392},{"month":8,"riseRate":0.5,"avgChangeRate":0.005017},{"month":9,"riseRate":0.5,"avgChangeRate":-0.014506},{"month":10,"riseRate":0.3,"avgChangeRate":-0.035326},{"month":11,"riseRate":0.6,"avgChangeRate":0.013984},{"month":12,"riseRate":0.5,"avgChangeRate":0.019361}],"exchange":"SEHK","name":"康臣药业","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康臣药业,01681,康臣药业股票,康臣药业股票老虎,康臣药业股票老虎国际,康臣药业行情,康臣药业股票行情,康臣药业股价,康臣药业股市,康臣药业股票价格,康臣药业股票交易,康臣药业股票购买,康臣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}